Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Calculated transaction value
$1.29M

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 30, 2026
Public filing date Jul 1, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$541.83 Jun 30, 2026
First close after public filing
$555.91 Jul 2, 2026
30-day return after filing
-6.87% Through Jul 31, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
9,500 shares @ $135.42
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001106578-26-000089
Filing cohort

Transactions in this filing

Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.43M
Buys / sales
0 / 11
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Current Exercise Jun 30, 2026 $1.29M
United Therapeutics Corp UTHR Sale Jun 30, 2026 $58.99K
United Therapeutics Corp UTHR Sale Jun 30, 2026 $278.55K
United Therapeutics Corp UTHR Sale Jun 30, 2026 $532.04K
United Therapeutics Corp UTHR Sale Jun 30, 2026 $706.77K
United Therapeutics Corp UTHR Sale Jun 30, 2026 $1.21M
United Therapeutics Corp UTHR Sale Jun 30, 2026 $1.35M
United Therapeutics Corp UTHR Sale Jun 30, 2026 $586.57K
United Therapeutics Corp UTHR Sale Jun 30, 2026 $239.05K
United Therapeutics Corp UTHR Sale Jun 30, 2026 $36.03K
United Therapeutics Corp UTHR Sale Jun 30, 2026 $7.65K
United Therapeutics Corp UTHR Sale Jun 30, 2026 $131.82K
United Therapeutics Corp UTHR Exercise Jun 30, 2026 $0